Flohale is a fluticasone propionate brand associated with inhaled corticosteroid therapy. Before publishing a listing for Flohale 2 mg Respules, confirm that the exact strength and presentation are available in the intended market. In particular, verify whether 2 mg refers to the total drug content in one respule or a concentration expressed per mL. These values are not interchangeable.
Flohale is a corticosteroid medicine used to control airway inflammation. It is not a rescue bronchodilator and should not be relied upon for immediate relief during an acute asthma attack. Use only according to the prescribed nebulised treatment regimen.
What Are Flohale 2 mg Respules?
Flohale 2 mg Respules are described as a nebulised formulation of fluticasone propionate, an inhaled corticosteroid used in the management of inflammatory respiratory conditions such as bronchial asthma.
Asthma is a chronic condition characterized by inflammation, swelling, and increased sensitivity of the bronchial airways.
Inflamed airways may become narrowed and produce symptoms such as wheezing, coughing, chest tightness, and difficulty breathing.
Fluticasone propionate works by reducing inflammatory activity in the respiratory tract.
It helps suppress inflammatory mediators, reduce airway swelling, and decrease sensitivity to asthma triggers.
Respules contain liquid medication intended for administration through a compatible nebuliser.
The nebuliser converts the medication into an inhalable aerosol that can reach the respiratory airways.
Nebulised treatment may be considered for selected patients who cannot use certain handheld inhalers effectively or who require a specific prescribed nebuliser regimen.
Unlike short-acting bronchodilators, fluticasone does not immediately relax tightened bronchial muscles.
Its primary purpose is to control inflammation and reduce the frequency of asthma symptoms over time.
Common Reasons for Prescribing Flohale Respules
- Maintenance treatment of bronchial asthma
- Control of chronic airway inflammation
- Prevention of recurrent asthma symptoms
- Reduction of asthma exacerbations
- Management of persistent asthma-related wheezing
- Control of asthma-related coughing
- Reduction of nighttime asthma symptoms
- Supportive management of airway hyperresponsiveness
- Nebulised corticosteroid treatment when clinically appropriate
- Long-term asthma management under medical supervision
Important: The approved indications and dosing of Flohale 2 mg Respules must be verified against the exact product labeling. Nebulised fluticasone should not be assumed interchangeable with other inhaled corticosteroid products.
How Do Flohale 2 mg Respules Work?
1. Deliver Fluticasone to the Airways
A compatible nebuliser converts the prescribed suspension into an inhalable aerosol.
2. Activate Glucocorticoid Receptors
Fluticasone propionate binds to intracellular glucocorticoid receptors in airway cells.
3. Suppress Inflammatory Mediators
The medicine reduces the activity of inflammatory signaling pathways involved in asthma.
4. Reduce Airway Swelling
Fluticasone helps decrease inflammation-related swelling in the bronchial lining.
5. Reduce Airway Hyperresponsiveness
Regular corticosteroid treatment can decrease excessive airway sensitivity to allergens and other triggers.
6. Help Control Mucus-Related Symptoms
Reducing inflammation may help limit excessive mucus production associated with asthma.
7. Reduce Asthma Exacerbation Risk
Appropriate inhaled corticosteroid treatment can reduce the frequency of asthma flare-ups.
8. Support Long-Term Respiratory Control
Consistent use may improve asthma stability and reduce the need for rescue bronchodilators.
Important: Fluticasone does not produce immediate bronchodilation and is not a substitute for emergency asthma treatment.
Uses of Flohale 2 mg Respules
1. Bronchial Asthma
Fluticasone propionate is used to control airway inflammation associated with bronchial asthma.
2. Persistent Asthma
It may be prescribed as part of maintenance treatment for patients with persistent asthma.
3. Prevention of Asthma Exacerbations
Regular inhaled corticosteroid treatment may reduce asthma flare-ups.
4. Asthma-Related Wheezing
Improved control of airway inflammation may reduce recurrent wheezing.
5. Asthma-Related Cough
Fluticasone may help reduce persistent coughing caused by asthma-related inflammation.
6. Nighttime Asthma Symptoms
Effective controller therapy may reduce nighttime coughing, wheezing, and breathlessness.
7. Airway Inflammation Control
Fluticasone suppresses inflammatory processes in the bronchial airways.
8. Airway Hyperresponsiveness
Regular treatment may reduce the tendency of airways to react excessively to asthma triggers.
9. Long-Term Asthma Management
Fluticasone may be included in a broader treatment plan involving controller and reliever medicines.
10. Nebulised Corticosteroid Therapy
Nebulised delivery may be appropriate for selected patients when the formulation is approved and prescribed.
11. Reduction of Rescue Inhaler Dependence
Improved asthma control may reduce the frequency of rescue bronchodilator use.
12. Specialist-Directed Respiratory Care
Other uses must be based on the approved product labeling and specialist assessment.
Important: Flohale Respules should not be marketed as a cure for asthma, a treatment for all respiratory infections, or an immediate-relief medicine for acute breathlessness.
Flohale 2 mg Respules Dosage and Administration
The appropriate dose depends on the patient’s age, respiratory condition, severity of asthma, previous corticosteroid exposure, and response to treatment.
General Dosage Information
| Dosage Information | Details |
|---|---|
| Active Ingredient | Fluticasone Propionate |
| Listed Strength | 2 mg; exact concentration must be verified |
| Dosage Form | Nebuliser Suspension |
| Administration Route | Inhalation through a nebuliser |
| Treatment Type | Anti-inflammatory Controller Therapy |
| Dose per Administration | As prescribed |
| Administration Frequency | According to the prescribed regimen |
| Treatment Duration | Determined by the healthcare professional |
| Pediatric Use | Depends on approved formulation, age, and dose |
| Emergency Asthma Relief | Not suitable |
| Medical Supervision | Required |
Important: A 2 mg respule strength does not establish an appropriate dose for every patient. The amount of medication administered must be determined from the verified product concentration and prescription.
How to Use Flohale Respules With a Nebuliser
- Wash and dry your hands before handling the respule.
- Confirm the medicine name, strength, and expiry date.
- Check that the respule is intact.
- Prepare the nebuliser according to its manufacturer’s instructions.
- Gently resuspend the medication if instructed on the product label.
- Open the respule carefully.
- Transfer the prescribed amount into the nebuliser medication chamber.
- Do not mix with other medicines unless compatibility has been confirmed.
- Attach the appropriate mouthpiece or face mask.
- Sit upright during nebulisation.
- Breathe normally through the mouthpiece or mask.
- Continue until the prescribed nebulisation session is complete.
- Turn off the nebuliser.
- Rinse the mouth with water and spit it out after treatment.
- Wash the face after use if a face mask was used.
- Clean and dry the nebuliser components according to the device instructions.
- Dispose of any unused medication as directed by the product label.
Can Flohale Respules Be Swallowed?
No.
Respules are intended for nebulised inhalation and must not be swallowed or injected.
Can Flohale Respules Be Used During an Asthma Attack?
Flohale is not a rapid-acting bronchodilator.
Patients experiencing sudden bronchospasm should follow their prescribed asthma action plan and use the appropriate rescue treatment.
Can Flohale Respules Be Mixed With Other Nebuliser Medicines?
Do not mix Flohale with salbutamol, levosalbutamol, ipratropium, or other nebuliser solutions unless the prescribing clinician or pharmacist confirms compatibility.
What If a Dose Is Missed?
Use the missed dose when remembered unless it is nearly time for the next scheduled dose.
If the next dose is due soon, skip the missed dose.
Do not double the dose.
Can Flohale Respules Be Stopped Suddenly?
Do not independently stop prescribed maintenance corticosteroid treatment.
Stopping treatment may worsen asthma control.
Patients transitioning from systemic corticosteroids may require additional medical supervision.
How Long Do Flohale 2 mg Respules Take to Work?
Fluticasone begins producing anti-inflammatory effects after inhalation, but symptom relief is not immediate.
Some improvement may occur within several days.
More consistent asthma control may develop over one to several weeks of regular treatment.
The response depends on asthma severity, adherence, nebuliser technique, and the prescribed regimen.
Fluticasone should not be relied upon for rapid relief of sudden wheezing or severe breathlessness.
Common Side Effects
Possible side effects include:
- Oral thrush
- Hoarseness
- Voice changes
- Throat irritation
- Mild coughing during nebulisation
- Sore throat
- Dry mouth
- Unpleasant taste
- Headache
- Mouth discomfort
- Throat dryness
- Mild respiratory irritation
Rinsing the mouth and spitting out the water after nebulisation can help reduce the risk of oral candidiasis.
Potentially Harmful Effects & Serious Health Risks
1. Oral Candidiasis
Fluticasone may increase the risk of fungal infection in the mouth and throat.
2. Hoarseness and Voice Changes
Inhaled corticosteroids may cause dysphonia.
3. Paradoxical Bronchospasm
Rarely, inhalation may cause sudden worsening of wheezing or breathing difficulty.
4. Adrenal Suppression
Prolonged high-dose corticosteroid exposure may suppress normal adrenal hormone production.
5. Growth Effects in Children
Long-term inhaled corticosteroid therapy may affect growth velocity.
6. Reduced Bone Mineral Density
Prolonged exposure to higher corticosteroid doses may contribute to reduced bone density.
7. Osteoporosis
Patients with additional risk factors may be more susceptible to corticosteroid-associated bone complications.
8. Cataracts
Long-term corticosteroid exposure may increase the risk of cataracts.
9. Glaucoma
Inhaled corticosteroids may contribute to increased eye pressure in susceptible patients.
10. Increased Susceptibility to Infections
Corticosteroids can influence immune responses, particularly when systemic exposure is increased.
11. Systemic Corticosteroid Effects
High doses or prolonged exposure may occasionally cause Cushingoid features and other systemic corticosteroid complications.
12. Serious Allergic Reactions
Rare hypersensitivity reactions may occur.
13. Drug Interaction-Related Toxicity
Certain medicines may increase systemic fluticasone exposure.
14. Inadequate Medicine Delivery
Incorrect nebuliser technique or an incompatible device may result in insufficient treatment.
15. Increased Systemic Exposure With High Doses
Higher corticosteroid exposure may increase the likelihood of systemic adverse effects.
Emergency warning: Seek immediate medical attention for severe breathing difficulty, sudden worsening of wheezing after nebulisation, facial or throat swelling, or signs of a serious allergic reaction.
Contraindications & Safety Precautions
1. Hypersensitivity to Fluticasone
Do not use the medicine if allergic to fluticasone propionate or any ingredient in the formulation.
2. Acute Asthma Attacks
Fluticasone should not be used as the sole treatment for an acute asthma attack.
3. Status Asthmaticus
Severe or life-threatening asthma requires emergency treatment.
4. Respiratory Infections
Patients with active respiratory infections may require additional assessment and treatment.
5. Tuberculosis
Patients with active or previous tuberculosis should inform their healthcare professional.
6. Fungal Infections
Inhaled corticosteroids may increase the risk of local fungal infections.
7. Oral Thrush
Patients who develop oral candidiasis may require antifungal treatment and a review of nebuliser technique.
8. Adrenal Disorders
Patients with adrenal suppression or prolonged previous systemic corticosteroid use require careful monitoring.
9. Liver Disease
Severe liver impairment may increase systemic corticosteroid exposure.
10. Osteoporosis
Patients with low bone mineral density may require additional monitoring during prolonged treatment.
11. Glaucoma and Cataracts
Patients with eye disorders should report visual changes.
12. Pregnancy
Maintaining good asthma control during pregnancy is important.
Fluticasone may be used when clinically appropriate, based on the healthcare professional’s assessment of benefits and risks.
13. Breastfeeding
Inhaled fluticasone is generally considered compatible with breastfeeding at prescribed doses, although individual circumstances should be reviewed.
14. Children
Pediatric use depends on the approved age range, formulation, and prescribed dose.
Growth should be monitored during long-term treatment.
15. Older Adults
Older patients may require additional monitoring for bone health and eye complications.
16. Nebuliser Compatibility
Use only a nebuliser compatible with the prescribed formulation.
17. Drug Interactions
Potentially important interactions include:
- Ritonavir: May substantially increase systemic fluticasone exposure.
- Cobicistat-Containing Medicines: May increase the risk of systemic corticosteroid effects.
- Ketoconazole: May increase fluticasone concentrations.
- Itraconazole: May increase systemic corticosteroid exposure.
- Other Strong CYP3A4 Inhibitors: May increase the risk of systemic corticosteroid adverse effects.
- Other Corticosteroids: May increase cumulative corticosteroid exposure.
18. Correct Nebuliser Technique
Incorrect technique may reduce medicine delivery and compromise asthma control.
19. Infection Prevention
Nebuliser equipment should be cleaned and maintained according to the manufacturer’s instructions.
20. Medical Monitoring
Healthcare professionals may monitor:
- Asthma symptom frequency
- Nighttime symptoms
- Rescue inhaler use
- Lung function
- Asthma exacerbations
- Nebuliser technique
- Oral thrush
- Hoarseness
- Growth in children
- Bone health when indicated
- Eye symptoms
- Adrenal function when clinically indicated
- Treatment adherence
- Need for dose adjustment
Advantages
- Inhaled corticosteroid therapy.
- Direct delivery to the respiratory airways.
- Helps control airway inflammation.
- Supports long-term asthma management.
- May reduce recurrent asthma symptoms.
- May reduce nighttime asthma symptoms.
- May prevent asthma exacerbations.
- May improve overall asthma control.
- May reduce reliance on rescue bronchodilators.
- Nebulised inhalation delivery.
- Suitable for selected patients requiring nebuliser treatment.
- Established anti-inflammatory mechanism.
- Supports individualized maintenance treatment.
Disadvantages / Limitations
- Does not provide immediate asthma relief.
- Requires a compatible nebuliser.
- Requires correct nebuliser technique.
- May cause oral thrush.
- May cause hoarseness.
- May cause throat irritation.
- May cause coughing during nebulisation.
- May cause paradoxical bronchospasm.
- High-dose exposure may cause adrenal suppression.
- Long-term use may affect growth velocity in children.
- Long-term exposure may affect bone health.
- May increase cataract or glaucoma risk.
- May interact with strong CYP3A4 inhibitors.
- Requires proper nebuliser cleaning.
- May require monitoring during prolonged treatment.
- Does not cure asthma permanently.
- Cannot replace emergency reliever treatment.
- Exact formulation and strength must be verified.
Important Notes
Generic Name: Fluticasone Propionate.
Product Name: Flohale 2 mg Respules.
Listed Strength: 2 mg; verify exact concentration and total drug content.
Drug Class: Inhaled Corticosteroid.
Therapeutic Category: Respiratory Medicine / Asthma Controller.
Primary Use: Maintenance treatment of bronchial asthma.
Mechanism: Suppression of inflammatory activity in the airways.
Administration Route: Nebulised Inhalation.
Dosage Form: Nebuliser Suspension / Respules.
Device: Compatible Nebuliser.
Major Warning: Not suitable for immediate relief during an acute asthma attack.
Common Side Effects: Oral thrush, hoarseness, and throat irritation.
Serious Risks: Adrenal suppression, paradoxical bronchospasm, and systemic corticosteroid effects.
Pregnancy: Use according to medical assessment.
Breastfeeding: Generally compatible at prescribed inhaled doses.
Pediatric Use: Follow age-specific product labeling.
Monitoring: Asthma control, nebuliser technique, oral health, and systemic corticosteroid effects when indicated.
Prescription Status: Prescription Medicine.
Storage: Follow manufacturer instructions.
Frequently Asked Questions
1. What are Flohale 2 mg Respules used for?
Flohale Respules contain fluticasone propionate, an inhaled corticosteroid used to control airway inflammation in selected patients with asthma.
2. What is the generic name of Flohale?
The generic name is fluticasone propionate.
3. Is Flohale a steroid medicine?
Yes. Fluticasone propionate is an inhaled corticosteroid.
4. How do Flohale Respules work?
They reduce inflammatory activity in the respiratory airways, helping control asthma symptoms over time.
5. Can Flohale Respules be swallowed?
No. Respules are intended for nebulised inhalation and must not be swallowed.
6. Do Flohale Respules require a nebuliser?
Yes. A compatible nebuliser is required for administration.
7. Can Flohale provide immediate asthma relief?
No. Flohale is an anti-inflammatory controller medicine and does not provide rapid bronchodilation.
8. Can Flohale help reduce wheezing?
Yes. Regular treatment may reduce wheezing associated with asthma-related inflammation.



































































Reviews
There are no reviews yet.